CG Oncology Confirms Nasdaq Listing for Common Stock (CGON)
Ticker: CGON · Form: 8-K · Filed: Jan 30, 2024 · CIK: 1991792
| Field | Detail |
|---|---|
| Company | Cg Oncology, Inc. (CGON) |
| Form Type | 8-K |
| Filed Date | Jan 30, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $19.00, $437.0 m |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, exchange-listing
TL;DR
**CG Oncology's 8-K confirms its common stock is listed on Nasdaq under CGON.**
AI Summary
CG Oncology, Inc. filed an 8-K on January 30, 2024, reporting an event that occurred on January 29, 2024. This filing primarily serves to update the public record regarding the company's status and its common stock, which trades under the symbol CGON on The Nasdaq Stock Market, LLC. For investors, this filing confirms the company's current registration details and its listing on a major exchange, which is foundational information for trading and valuation.
Why It Matters
This filing confirms CG Oncology's listing on The Nasdaq Stock Market, LLC, under the ticker CGON, providing transparency and official documentation for investors regarding its publicly traded status.
Risk Assessment
Risk Level: low — This filing is largely administrative, confirming existing information, and does not introduce new financial or operational risks.
Analyst Insight
A smart investor would use this filing to confirm the official trading details of CG Oncology, Inc. (CGON) on Nasdaq, ensuring they have accurate information for any investment decisions or portfolio tracking.
Key Numbers
- $0.0001 — Par Value per Share (The par value of CG Oncology, Inc.'s common stock.)
Key Players & Entities
- CG Oncology, Inc. (company) — the registrant filing the 8-K
- The Nasdaq Stock Market, LLC (company) — the exchange where CG Oncology's common stock is registered
- CGON (company) — the trading symbol for CG Oncology's common stock
- January 29, 2024 (date) — date of earliest event reported
- January 30, 2024 (date) — date of filing
- $0.0001 (dollar_amount) — par value per share of common stock
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is CG Oncology, Inc.
On which stock exchange is CG Oncology, Inc.'s common stock registered?
CG Oncology, Inc.'s common stock, with a par value of $0.0001 per share, is registered on The Nasdaq Stock Market, LLC.
What is the trading symbol for CG Oncology, Inc.'s common stock?
The trading symbol for CG Oncology, Inc.'s common stock is CGON.
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 29, 2024.
What is the Commission File Number for CG Oncology, Inc.?
The Commission File Number for CG Oncology, Inc. is 001-41925.
Filing Stats: 994 words · 4 min read · ~3 pages · Grade level 13.7 · Accepted 2024-01-30 07:10:30
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CGON The Nasdaq Stock Mar
- $19.00 — l shares, at a public offering price of $19.00 per share. The gross proceeds to the Co
- $437.0 m — oceeds to the Company from the IPO were $437.0 million, before deducting underwriting di
Filing Documents
- d114617d8k.htm (8-K) — 29KB
- d114617dex31.htm (EX-3.1) — 37KB
- d114617dex32.htm (EX-3.2) — 172KB
- 0001193125-24-018715.txt ( ) — 413KB
- cgon-20240129.xsd (EX-101.SCH) — 3KB
- cgon-20240129_lab.xml (EX-101.LAB) — 19KB
- cgon-20240129_pre.xml (EX-101.PRE) — 12KB
- d114617d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CG Oncology, Inc. Date: January 30, 2024 By: /s/ Arthur Kuan Name: Arthur Kuan Title: Chairman and Chief Executive Officer 2